» Articles » PMID: 19247689

Saline Extract of Taenia Saginata Metacestodes As an Alternative Antigen for the Immunodiagnosis of Neurocysticercosis in Human Cerebrospinal Fluid

Overview
Journal Parasitol Res
Specialty Parasitology
Date 2009 Feb 28
PMID 19247689
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present research was to test the application of Taenia saginata metacestodes as an alternative antigen for use in enzyme-linked immunosorbent assay (ELISA) and Western Blotting (WB) tests compared with the use of metacestodes antigen of Taenia solium in cerebrospinal fluid (CSF) samples. The samples were obtained from 35 patients with definitive neurocysticercosis (NCC)-group 1-and 44 patients with other neurological disorders (control)-group 2. The sensitivity and specificity of ELISA, using antigen obtained from T. solium, applied to the patients of group 1 yielded results of 100%. When the tests were conducted using T. saginata metacestodes, results were 100% and 93.2%, respectively. The 47-52-, 64-68-, and 70-kDa antigens showed high frequencies in CSF samples from patients with NCC when WB was conducted with both antigens. The results indicate that T. saginata metacestodes can be used as an alternative antigen for the diagnosis of human NCC in CSF samples.

Citing Articles

Antiparasitic treatment of cerebral cysticercosis: lessons and experiences from China.

Wu W, Jia F, Wang W, Huang Y, Huang Y Parasitol Res. 2013; 112(8):2879-90.

PMID: 23695946 DOI: 10.1007/s00436-013-3459-3.


Immunodiagnosis of neurocysticercosis: ways to focus on the challenge.

Esquivel-Velazquez M, Ostoa-Saloma P, Morales-Montor J, Hernandez-Bello R, Larralde C J Biomed Biotechnol. 2011; 2011:516042.

PMID: 22131808 PMC: 3205906. DOI: 10.1155/2011/516042.


Taenia saginata metacestode antigenic fractions without affinity to concanavalin A are an important source of specific antigens for the diagnosis of human neurocysticercosis.

Oliveira H, Machado G, Mineo J, Costa-Cruz J Clin Vaccine Immunol. 2010; 17(4):638-44.

PMID: 20130125 PMC: 2849342. DOI: 10.1128/CVI.00516-09.

References
1.
Del Brutto O, Wadia N, Dumas M, Cruz M, Tsang V, Schantz P . Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci. 1996; 142(1-2):1-6. DOI: 10.1016/0022-510x(96)00130-x. View

2.
Husain N, Shukla N, Kumar R, Husain M, Chaturvedi A, Agarwal G . ELISA in the evaluation of therapeutic response to albendazole in neurocysticercosis. J Infect. 2007; 56(1):65-73. DOI: 10.1016/j.jinf.2007.09.014. View

3.
Montero E, Gonzalez L, Harrison L, Parkhouse R, Garate T . Taenia solium cDNA sequence encoding a putative immunodiagnostic antigen for human cysticercosis. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 786(1-2):255-69. DOI: 10.1016/s1570-0232(02)00909-1. View

4.
Takayanagui O, Odashima N . Clinical aspects of neurocysticercosis. Parasitol Int. 2005; 55 Suppl:S111-5. DOI: 10.1016/j.parint.2005.11.016. View

5.
Garcia H, Del Brutto O, Nash T, White Jr A, Tsang V, Gilman R . New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg. 2005; 72(1):3-9. View